Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q1 2023 Earn

Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics First Quarter 2023 Earnings Call. At this time, participants are in a listen-only mode. As a reminder this call is being recorded.

Related Keywords

Canada , Israel , United States , California , Japan , American , America , Antonio Trejo , Chaim Lebovits , Kirk Taylor , Stacy Lindborg , David Bautz , Michael Wood , Richard Robbins , Dan Michael , Vp Regulatory Affairs , Novartis , Nasdaq , Amgen , Serono , Research Summit , Brainstorm Cell Therapeutics Inc , Advisory Committee Meeting , Vp North American Medical Affairs , Company Executive , Association Clinical , Brainstorm Cell Therapeutics , Call Transcript May , Cell Therapeutics , Brainstorm Cell Therapeutics First Quarter , Co Chief Executive Officer , Alla Patlis , Interim Chief Financial , Chief Medical Officer , Nurown Phase , Muscular Dystrophy , Scientific Meeting , California Annual , Advisory Committee , Executive Vice President , Chief Medical , American Medical Affairs , Robin Wallace , Vice President Global Clinical ,